Literature DB >> 17362774

Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis.

P Schemmer1, A Nickkholgh, U Hinz, T Gerling, A Mehrabi, P Sauer, J Encke, H Friess, J Weitz, M W Büchler, J Schmidt.   

Abstract

The organ shortage has driven many transplant centers to accept extended donor criteria and to modify graft allocation policies. This study was designed to analyze the impact of applying extended donor criteria (EDC) in orthotopic liver transplantation (OLT). Between December 2001 and December 2004, we performed 165 primary cadaveric whole OLTs. Up to three EDC, that is, ventilation >7 days; aminotransferases (ALT or AST) >3 x normal; bilirubin >3 mg/dL; anti-HBc or HBs Ag positivity; donor age >65 years; liver steatosis >40%; donor body mass index >30; cold ischemia time >14 hours; peak serum Na(+) >165 mmol/L; history of extrahepatic malignancy; or previous drug abuse were present in 55% of all grafts. Both univariate and multivariate analysis revealed that EDC status had no effect on graft or patient survival, the necessity for retransplantation, the length of intensive care/intermediate care unit stay, mechanical ventilation, complications, or posttransplant laboratory findings. Recipient age of >/=55 years was the only independent prognostic factor for survival, regardless of EDC. These findings suggested that the use of grafts from EDC donors are safe and expand the donor pool.

Entities:  

Mesh:

Year:  2007        PMID: 17362774     DOI: 10.1016/j.transproceed.2006.12.002

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  17 in total

1.  Intercontinental comparison of patient cohorts: what can we learn from it?

Authors:  P Schemmer; L Fischer; J Schmidt; M W Büchler
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

2.  [Liver transplantation. From innovation to routine].

Authors:  M W Büchler
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

Review 3.  [Expanding the liver donor pool through extended-criteria donation].

Authors:  J Pratschke; J Mittler; P Neuhaus
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

4.  Isolation of human hepatocytes by a two-step collagenase perfusion procedure.

Authors:  Serene M L Lee; Celine Schelcher; Maresa Demmel; Maria Hauner; Wolfgang E Thasler
Journal:  J Vis Exp       Date:  2013-09-03       Impact factor: 1.355

5.  The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.

Authors:  Karli J Moncrief; Anamaria Savu; Mang M Ma; Vince G Bain; Winnie W Wong; Puneeta Tandon
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

Review 6.  Donor liver histology--a valuable tool in graft selection.

Authors:  Christa Flechtenmacher; Peter Schirmacher; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2015-03-26       Impact factor: 3.445

7.  [Orthotopic liver transplantation. Techniques and results].

Authors:  J Schmidt; S A Müller; A Mehrabi; P Schemmer; M W Büchler
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

8.  Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation.

Authors:  Sascha A Müller; Bruno M Schmied; Arianeb Mehrabi; Thilo Welsch; Peter Schemmer; Ulf Hinz; Jürgen Weitz; Jens Werner; Markus W Büchler; Jan Schmidt
Journal:  J Gastrointest Surg       Date:  2008-11-26       Impact factor: 3.452

Review 9.  Current concepts in transplant surgery: liver transplantation today.

Authors:  A Mehrabi; H Fonouni; S A Müller; J Schmidt
Journal:  Langenbecks Arch Surg       Date:  2008-02-29       Impact factor: 3.445

10.  HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation.

Authors:  Qinlong Liu; Helge Bruns; Daniel Schultze; Yi Xue; Markus Zorn; Christa Flechtenmacher; Beate K Straub; Ursula Rauen; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2012-11-01       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.